
Stillingia treculeana, queen’s root, queen’s delight, yaw root
Derived from the root of the plant, this supplement is used to treat syphilis, bronchitis, constipation, hemorrhoids, skin conditions, and is an ingredient in the Hoxsey herbal tonic used as a cancer treatment. Stillingia contains diterpene esters that cause mucosal irritation and skin eruptions. Other reported toxicities include vertigo, diarrhea, nausea, vomiting, muscle ache, pruritus, cough, fatigue, and sweating. No clinical data support the use of this supplement for any proposed claim.
Significant toxicity can occur following administration (1).
No studies have evaluated stillingia for any proposed claim. Stillingia contains diterpene esters, toxic irritants that can cause swelling and inflammation of the skin (1). In vitro research suggests that diterpene esters may have antitumor activity (2), but this has not been confirmed with stillingia root.
The diterpene esters in stillingia are irritants to the skin and mucous membranes (1).
Toxicity: Vertigo, burning sensation on mucous membranes, diarrhea, nausea, vomiting, muscle ache, pruritus, skin eruptions, cough, fatigue, sweating (1).
None known.
Bottom Line: There is no evidence to support use of Stillingia to treat cancer, infections, or other medical conditions.
Stillingia is a root extract. It is known to contain chemicals called diterpene esters, toxic irritants that can cause swelling and inflammation of the skin. One laboratory experiment suggested that diterpene esters can halt the growth of cancer cells, but this has not been confirmed with stillingia root.
There is no scientific evidence to support any of the uses below: